Obamacare: health reform’s tough start
November 1, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Medicare, Obama, Obamacare, US, affordable care act
On Tuesday 1 October, three years after it was passed, the Patient Protection and Affordable Care Act came into force …
Ariad cancer drug pulled amid safety fears
November 1, 2013Sales and Marketing Ariad, FDA, iclusig, leukaemia
Ariad Pharmaceuticals has been forced by the FDA to suspend sales of its blood cancer drug Iclusig given the high …
More changes at the top as AstraZeneca profits slip
November 1, 2013Sales and Marketing AstraZeneca, Crestor, Q3, profits
AstraZeneca’s third quarter revenues and profits fell below analysts’ expectations yesterday, but mitigated the news with the appointment of a …
AstraZeneca hires former GSK head as CFO
November 1, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, GSK, dunoyer
AstraZeneca has confirmed that Marc Dunoyer has been appointed chief financial officer and will join the company’s Board as an …
Heartbeat Ideas joins forces with Saatchi & Saatchi Health
October 31, 2013Medical Communications health, heartbeat, saatchi
Publicis Groupe has announced that its digital health agency Heartbeat Ideas has joined Saatchi & Saatchi Health in the US. …
Teva boss quits over Board struggles
October 31, 2013Medical Communications, Sales and Marketing Copaxone, Levin, Teva, generics
Teva’s president and chief executive Dr Jeremy Levin has unexpectedly quit as the firm struggles with staff cuts and management …
Almac appoints US vice president of business development


October 31, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Almac, seigel
Contract manufacturing firm Almac has hired Richard Segiel Jr as its vice president of Business Development for the US. He …
Sanofi cuts earnings guidance despite return to sales growth
October 31, 2013Sales and Marketing Sanofi, Viehbacher, vaccines
Sanofi cut its earnings guidance for 2013 after its third quarter results missed targets, despite a return – barely – …
GSK strikes new vaccines deal with Gates Foundation
October 30, 2013Research and Development, Sales and Marketing GSK, Gates, bmgf, vaccines
GSK and the Bill & Melinda Gates Foundation (BMGF) will invest a combined $1.8 million in early-stage research into making …
Cancer drugs lift Pfizer in third quarter
October 30, 2013Sales and Marketing Lipitor, Lyrica, Pfizer, Q3, Xalkori
Pfizer saw a drop in revenue for the third quarter but the future looks bright as new products begin to …
Unpublished trials ‘violates ethical obligation’ to patients
October 30, 2013Research and Development, Sales and Marketing BMJ, Goldacre, all trials, trials
A new study published in the BMJ has found almost one in three (29%) of large clinical trials remain unpublished …
Aesica hires business development manager and director
October 30, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Aesica, muganga
Contract development and manufacturing organisation (CDMO) Aesica has appointed Baali Muganga to the role of east coast US business development …
‘Game-changing’ hep C pill gets FDA panel nod
October 29, 2013Sales and Marketing FDA, Gilead, hep C, sofosbuvir
Gilead Science’s investigational hepatitis C drug sofosbuvir is one step closer to approval in the US after an FDA advisory …
Strong sales for Biogen Idec’s MS drug
October 29, 2013Sales and Marketing Biogen IDEC, Q3, gilenya, tecfidera
Biogen Idec’s oral multiple sclerosis (MS) drug Tecfidera lived up to its blockbuster-in-waiting billing with third quarter sales that exceeded …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
